(Oxford, UK, 07 September 2016) Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune disease, is delighted to announce that it won the “Private UK Life Science Company of the Year” award at the 2016 Biotech and Money Assembly and Awards. Eliot Forster, Chief Executive Officer of Immunocore was also named “UK Life Science CEO of the Year” at the event.
Dr Eliot Forster, Chief Executive Officer of Immunocore, commented: “We are delighted to have been presented with these awards, particularly given the calibre of the other nominees. This has been an important period for Immunocore and these awards reflect the great progress we have made in developing our ImmTAC technology over the last year. I would like to thank the Immunocore team for their hard work, dedication and support throughout the past year.”
Please click on the link below to download the full Press Release: